Effect of a bioactive product SEL001 from Lactobacillus sakei probio65 on gut microbiota and its anti-colitis effects in a TNBS-induced colitis mouse model

This study underpins the therapeutic potential of SEL001, a bioactive product isolated from Lactobacillus sakei probio65, in terms of its anti-inflammatory properties and its effect on gut-microbiota in a TNBS-induced ulcerative colitis mouse model. Ulcerative colitis was developed in mice by intra...

Descripción completa

Detalles Bibliográficos
Autores principales: Rather, Irfan A., Bajpai, Vivek K., Ching, Lew L., Majumder, Rajib, Nam, Gyeong-Jun, Indugu, Nagaraju, Singh, Prashant, Kumar, Sanjay, Hajrah, Nahid H., Sabir, Jamal S.M., Kamli, Majid Rasool, Park, Yong-Ha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933275/
https://www.ncbi.nlm.nih.gov/pubmed/31889846
http://dx.doi.org/10.1016/j.sjbs.2019.09.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933275/
https://www.ncbi.nlm.nih.gov/pubmed/31889846
http://dx.doi.org/10.1016/j.sjbs.2019.09.004

Ejemplares similares